AIMOVIG
AIMOVIG
Approved
DIN Number
02479613
Drug Class
Human
Market Date
Dec 4, 2018
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02479613
AIG Number0160530001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
N02CD01 ERENUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification28:32.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
ERENUMABActive
Strength: 70 MG / ML
Monograph: ERENUMAB